DSIP (Delta Sleep-Inducing Peptide)

DSIP is a peptide discussed in research concerning sleep physiology and nervous-system function. The supplied guide associates it with sleep, stress, and pain, but these notes do not establish therapeutic benefit.

The guide characterizes DSIP as an endogenous neuropeptide and attributes its initial isolation to rabbit brainstem tissue. The historical account and the characterization of its physiological role require verification against primary literature.

The source presents sleep-related signaling, stress responses, and pain processing as proposed areas of biological activity. It does not identify a specific receptor, molecular interaction, or experimentally established pathway that explains these proposed effects.

1. 01

   Molecular target

2. 02

   Cellular signal

3. 03

   Biological process

LEVEL 01 · Basic biology

A biological mechanism or molecular interaction is described. No claim about human outcomes.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

The source describes DSIP as relevant to sleep quality and responses to stress. It also suggests possible relevance to pain and anxiety, without supplying evidence sufficient to assess those claims. Its suggested literature searches extend to neuroprotection and insomnia, but search topics alone do not substantiate clinical applications.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

The supplied material does not clarify which claims derive from animal experiments, human investigations, or speculation. DSIP's mechanisms, clinical relevance, and reproducibility of reported effects remain unresolved on the basis of these notes.

Safety data are limited, and the guide's favorable tolerability characterization cannot establish a reliable safety profile. The source mentions sleepiness and short-lived headache, but provides no supporting information sufficient to determine their frequency or severity. This summary is not medical advice.

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

• “Delta sleep-inducing peptide (DSIP) sleep disorders”
• “DSIP peptide neuroprotective effects”
• “Clinical uses of DSIP for insomnia”

Editorial status

source reviewed

Last updated

2026-09-14

Last reviewed

2026-09-13

Language

EN